Full Press Release Details
ABBOTT PARK , Ill. , Sept. 5, 2024 /PRNewswire/ -- Abbott (NYSE: ABT ) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness. Lingo is based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology 1 , now used by more than 6 million people with diabetes globally 1 .
"There is a great deal of interest in tracking biomarkers that provide insights into one's health and wellness that were previously undetectable using the trackers available to consumers," said Olivier Ropars , divisional vice president of Abbott's Lingo business. "Glucose is a powerful signal of your body's unique response to food and lifestyle. Abbott's Lingo tracks your glucose 24/7, translating the data into insights and bridging the gap between traditional healthcare and preventative measures. Lingo empowers individuals to build new healthy habits and take control of their health and wellness."
Abbott's consumer biowearable, Lingo, is available for consumers 18 years and older not on insulin. Lingo tracks glucose in real-time and provides personal insights and coaching to help people build healthy habits, retrain their metabolism and improve their overall well-being.
Health benefits of continuous glucose monitors (CGMs) and limiting glucose spikes
Compelling published research shows that limiting glucose spikes and improving overall management of glucose, both in the short term and over time, offer a number of health benefits for people who do not have diabetes. When equipped with real-time data and insights from a CGM, individuals can work towards these goals, experiencing benefits such as:
"Physical activity and nutrition are two major factors that impact glucose variability and while glucose spikes are normal, fewer spikes and crashes are associated with numerous short-term and long-term health benefits," said Fred St. Goar , M.D., cardiologist and medical director of El Camino Health Heart and Vascular Institute. "Understanding your body's glucose is key to managing your metabolism, so you can live healthier and better. CGMs are a powerful tool that I recommend to my patients to help them better understand what is going on inside their bodies, so they can take actional steps to improve mood, focus, energy, sleep, reduced cravings, and improve their health outcomes."
The Lingo system combines a biosensor that is worn on the back of the arm for up to 14 days 2 and continuously streams glucose data to the Lingo app on a smart phone – translating the body's reaction to food, exercise and life's daily stressors.
Key features of the Lingo experience:
Lingo is available in three convenient options:
Abbott announced FDA clearance of Lingo in June. The Lingo app is available in the App Store®. For more information and to purchase Lingo, please visit HelloLingo.com . Connect with Lingo on Facebook at www.facebook.com/HelloLingo and Instagram @HelloLingo .
Lingo is also available in the UK.
Press assets including images and B-roll available here .
About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com and on LinkedIn , Facebook , Instagram , X and YouTube .
About Lingo: The Lingo Glucose System is intended for users 18 years and older not on insulin. It is not intended for diagnosis of diseases, including diabetes.
The Lingo program does not guarantee that everyone will achieve the same results as individual responses may vary. Consult your healthcare professional before making changes to your diet or exercise regimen or if you have an eating disorder or a history of eating disorders.